UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Mechanism of Active Renal Tubular Efflux of Tenofovir

Antimicrobial Agents and Chemotherapy, 2006-10, Vol.50 (10), p.3297-3304

2006

Volltextzugriff (PDF)

Cobicistat (GS-9350): A Potent and Selective Inhibitor of Human CYP3A as a Novel Pharmacoenhancer

ACS medicinal chemistry letters, 2010-08, Vol.1 (5), p.209-213

2010

Volltextzugriff (PDF)

Structure–activity relationships of diamine inhibitors of cytochrome P450 (CYP) 3A as novel pharmacoenhancers, part I: Core region

Bioorganic & medicinal chemistry letters, 2014-02, Vol.24 (3), p.989-994

2014

Volltextzugriff (PDF)

Structure–activity relationships of diamine inhibitors of cytochrome P450 (CYP) 3A as novel pharmacoenhancers. Part II: P2/P3 region and discovery of cobicistat (GS-9350)

Bioorganic & medicinal chemistry letters, 2014-02, Vol.24 (3), p.995-999

2014

Volltextzugriff (PDF)

Nucleotide Analogue Prodrug Tenofovir Disoproxil Enhances Lymphoid Cell Loading following Oral Administration in Monkeys

Molecular pharmaceutics, 2009-08, Vol.6 (4), p.1145-1151

2009

Volltextzugriff (PDF)

Plasma Metabolomics Implicates Modified Transfer RNAs and Altered Bioenergetics in the Outcomes of Pulmonary Arterial Hypertension

Circulation (New York, N.Y.), 2017-01, Vol.135 (5), p.460-475

2017

Volltextzugriff (PDF)

Using the Plasma Proteome for Risk Stratifying Patients with Pulmonary Arterial Hypertension

American journal of respiratory and critical care medicine, 2022-05, Vol.205 (9), p.1102-1111

2022

Volltextzugriff (PDF)

Blood DNA methylation profiling identifies cathepsin Z dysregulation in pulmonary arterial hypertension

Nature communications, 2024-01, Vol.15 (1), p.330-330, Article 330

2024

Volltextzugriff (PDF)

Simvastatin as a Treatment for Pulmonary Hypertension Trial

American journal of respiratory and critical care medicine, 2010-05, Vol.181 (10), p.1106-1113

2010

Volltextzugriff (PDF)

Whole-Blood RNA Profiles Associated with Pulmonary Arterial Hypertension and Clinical Outcome

American journal of respiratory and critical care medicine, 2020-08, Vol.202 (4), p.586-594

2020

Volltextzugriff (PDF)

An Orally Bioavailable Antipoxvirus Compound (ST-246) Inhibits Extracellular Virus Formation and Protects Mice from Lethal Orthopoxvirus Challenge

Journal of Virology, 2005-10, Vol.79 (20), p.13139-13149

2005

Volltextzugriff (PDF)

Autoimmunity Is a Significant Feature of Idiopathic Pulmonary Arterial Hypertension

American journal of respiratory and critical care medicine, 2022-07, Vol.206 (1), p.81-93

2022

Volltextzugriff (PDF)

Rare variant analysis of 4241 pulmonary arterial hypertension cases from an international consortium implicates FBLN2, PDGFD, and rare de novo variants in PAH

Genome medicine, 2021-05, Vol.13 (1), p.80-18, Article 80

2021

Volltextzugriff (PDF)

National variation in coronary angiography rates and timing after an acute coronary syndrome in New Zealand (ANZACS-QI 6)

New Zealand medical journal, 2016-01, Vol.129 (1428), p.66-78

Williams, Michael J. A

2016

Volltextzugriff (PDF)

Identification of rare sequence variation underlying heritable pulmonary arterial hypertension

Nature communications, 2018-12, Vol.9 (1)

2018

Volltextzugriff (PDF)

Frequency and Nature of Rumination in Chronic Depression: A Preliminary Study

Cognitive behaviour therapy, 2008-09, Vol.37 (3), p.160-168

2008

Volltextzugriff (PDF)

N-(3,3a,4,4a,5,5a,6,6a-Octahydro-1,3-dioxo-4,6- ethenocycloprop[f]isoindol-2-(1H)-yl)carboxamides: Identification of Novel Orthopoxvirus Egress Inhibitors

Journal of medicinal chemistry, 2007-04, Vol.50 (7), p.1442-1444

2007

Volltextzugriff (PDF)

Variation in Arterial Access for Invasive Coronary Procedures in New Zealand: A national analysis (ANZACS-QI 5)

Heart, lung & circulation, 2016-05, Vol.25 (5), p.451-458

2016

Volltextzugriff (PDF)

The discovery and structure–activity relationships of pyrano[3,4- b]indole based inhibitors of hepatitis C virus NS5B polymerase

Bioorganic & medicinal chemistry letters, 2010-05, Vol.20 (9), p.2968-2973

2010

Volltextzugriff (PDF)

Sociality in Methadone Treatment: understanding methadone treatment and service delivery as a social process

Drugs : education, prevention & policy, 2000-05, Vol.7 (2), p.163-178

2000

Volltextzugriff (PDF)

Juggling Multiple Roles: Staff and Client Perceptions of Keyworker Roles and the Constraints on Delivering Counselling and Support Services in Methadone Treatment

Addiction research, 1999, Vol.7 (4), p.267-289

1999

Volltextzugriff (PDF)

1 – 25 von 28

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(26)
Mit Volltextzugriff
(27)

Publikationsform

Artikel
(28)

Sprache

Englisch
(28)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Mechanism of Active Renal Tubular Efflux of Tenofovir

Cobicistat (GS-9350): A Potent and Selective Inhibitor of Human CYP3A as a Novel Pharmacoenhancer

Structure–activity relationships of diamine inhibitors of cytochrome P450 (CYP) 3A as novel pharmacoenhancers, part I: Core region

Structure–activity relationships of diamine inhibitors of cytochrome P450 (CYP) 3A as novel pharmacoenhancers. Part II: P2/P3 region and discovery of cobicistat (GS-9350)

Nucleotide Analogue Prodrug Tenofovir Disoproxil Enhances Lymphoid Cell Loading following Oral Administration in Monkeys

Plasma Metabolomics Implicates Modified Transfer RNAs and Altered Bioenergetics in the Outcomes of Pulmonary Arterial Hypertension

Using the Plasma Proteome for Risk Stratifying Patients with Pulmonary Arterial Hypertension

Blood DNA methylation profiling identifies cathepsin Z dysregulation in pulmonary arterial hypertension

Simvastatin as a Treatment for Pulmonary Hypertension Trial

Whole-Blood RNA Profiles Associated with Pulmonary Arterial Hypertension and Clinical Outcome

An Orally Bioavailable Antipoxvirus Compound (ST-246) Inhibits Extracellular Virus Formation and Protects Mice from Lethal Orthopoxvirus Challenge

Traffic exposures, air pollution and outcomes in pulmonary arterial hypertension: a UK cohort study analysis

Biological heterogeneity in idiopathic pulmonary arterial hypertension identified through unsupervised transcriptomic profiling of whole blood

Autoimmunity Is a Significant Feature of Idiopathic Pulmonary Arterial Hypertension

Rare variant analysis of 4241 pulmonary arterial hypertension cases from an international consortium implicates FBLN2, PDGFD, and rare de novo variants in PAH

National variation in coronary angiography rates and timing after an acute coronary syndrome in New Zealand (ANZACS-QI 6)

Identification of rare sequence variation underlying heritable pulmonary arterial hypertension

Frequency and Nature of Rumination in Chronic Depression: A Preliminary Study

N-(3,3a,4,4a,5,5a,6,6a-Octahydro-1,3-dioxo-4,6- ethenocycloprop[f]isoindol-2-(1H)-yl)carboxamides: Identification of Novel Orthopoxvirus Egress Inhibitors

Variation in Arterial Access for Invasive Coronary Procedures in New Zealand: A national analysis (ANZACS-QI 5)

The discovery and structure–activity relationships of pyrano[3,4- b]indole based inhibitors of hepatitis C virus NS5B polymerase

The Discovery of Pyrano[3,4-b]indole-Based Allosteric Inhibitors of HCV NS5B Polymerase with In Vivo Activity

Plasma Metabolomics Implicate Modified Transfer RNAs and Altered Bioenergetics in the Outcome of Pulmonary Arterial Hypertension

Sociality in Methadone Treatment: understanding methadone treatment and service delivery as a social process

Juggling Multiple Roles: Staff and Client Perceptions of Keyworker Roles and the Constraints on Delivering Counselling and Support Services in Methadone Treatment

Suchergebnisse filtern